Aptar Pharma Expands Preservative Free Technology Production in Latin America
The original release is unavailable here.
Earlier from AptarGroup
- Aptar and Aceso Therapeutics Announce Collaboration to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis
- Aptar Reports Second Quarter 2026 Results
- Aptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive Year
- Aptar Pharma Announces GMP Certification at Nanopharm, Strengthening Its Integrated Pharma Services Offering
- Aptar Beauty Launches Next-Generation Auto-Loading Dropper Technology for Easier, More Accurate Skincare Dosing
Later from AptarGroup
- Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery
- Aptar Pharma Launches Premia™ Precision, a New Quality Standard for Demanding Injectable Therapies
- Aptar Announces CE Marking for LuerVax® and Accompanying Spray Divider, Strengthening Support for Vaccine Developers
- Aptar Taps Pharma Packaging Veteran Virginie Maes as President of its Pharma Business
- Aptar Pharma Acquires Pulmotree, Expanding Growth Opportunities in Next-Generation Pulmonary Drug Delivery
Follow AptarGroup into a list and get an email when it puts out news.
Follow AptarGroup